Secondary Parkinsonism Latest Advances

Find the Latest Research About Secondary Parkinsonism

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7161 publications

Encephalitis lethargica in Sweden, 1920-1930: national incidence and the 1921 outbreak in northern Sweden.

Encephalitis lethargica in Sweden, 1920-1930: national incidence and the 1921 outbreak in northern Sweden.

Journal: Epidemiology and infection

Published: September 08, 2026

A pickleball program for people living with Parkinson disease: a feasibility and preliminary results study.

A pickleball program for people living with Parkinson disease: a feasibility and preliminary results study.

Journal: Disability and rehabilitation

Published: July 30, 2026

Rare hereditary and acquired diseases with parkinson's syndrome

Rare hereditary and acquired diseases with parkinson's syndrome

Journal: Fortschritte der Neurologie-Psychiatrie

Published: July 02, 2026

Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.

Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.

Journal: NCHS data brief

Published: June 10, 2026

Striatal small RNA remodeling in MPTP-induced Parkinson's disease highlights coordinated downregulation of mitochondrial tsRNAs.

Striatal small RNA remodeling in MPTP-induced Parkinson's disease highlights coordinated downregulation of mitochondrial tsRNAs.

Journal: Frontiers in aging neuroscience

Published: May 18, 2026

Neurobehavioral Evaluation of Renin-Angiotensin System Modulators in an MPTP-Induced Model of Parkinson's Disease in Swiss Albino Mice.

Neurobehavioral Evaluation of Renin-Angiotensin System Modulators in an MPTP-Induced Model of Parkinson's Disease in Swiss Albino Mice.

Journal: Annals of African medicine

Published: May 11, 2026

Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson's disease.

Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson's disease.

Journal: Science advances

Published: May 01, 2026

Reversible subacute secondary parkinsonism due to neuroborreliosis with characteristic MRI evolution.

Reversible subacute secondary parkinsonism due to neuroborreliosis with characteristic MRI evolution.

Journal: BMJ case reports

Published: April 29, 2026

A Structure-Based Platform for Predicting Chemical-Induced Parkinson's Disease.

A Structure-Based Platform for Predicting Chemical-Induced Parkinson's Disease.

Journal: Chemical research in toxicology

Published: April 29, 2026

Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.

Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.

Journal: Diabetology & metabolic syndrome

Published: April 21, 2026

Tracking ClO- Dynamics during the Progression of Parkinson's Disease in MPTP Mouse Model Using In Vivo Brain Microdialysis.

Tracking ClO- Dynamics during the Progression of Parkinson's Disease in MPTP Mouse Model Using In Vivo Brain Microdialysis.

Journal: ACS chemical neuroscience

Published: April 15, 2026

Erucic acid protected against dopamine neuron degeneration by attenuating oxidative stress and neuroinflammation via PI3K/AKT signaling in Parkinson's disease.

Erucic acid protected against dopamine neuron degeneration by attenuating oxidative stress and neuroinflammation via PI3K/AKT signaling in Parkinson's disease.

Journal: Journal of neuroimmunology

Published: March 17, 2026

Showing 1-12 of 7,161

Last Updated: 09/26/2026